Moderna says its low-dose COVID vaccine works for kids 6 to 11
Published
Moderna says its clinical trials showed two doses that were half the size of its adult shots produced similar levels of virus-fighting antibodies in children.
Full ArticlePublished
Moderna says its clinical trials showed two doses that were half the size of its adult shots produced similar levels of virus-fighting antibodies in children.
Full ArticleWatch VideoThe Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19..
Shares of Moderna (NYSE: MRNA) traded 7% higher on Monday, after receiving positive results from their Covid 19 vaccine for kids...